Fennec Pharmaceuticals Inc. Common Stock FENC
$12.17
+3.93%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-13 | View → |
| 4 | Insider transaction | 2026-08-04 | View → |
| 4 | Insider transaction | 2026-08-03 | View → |
| 4 | Insider transaction | 2026-08-03 | View → |
| 4 | Insider transaction | 2026-08-03 | View → |
| 4 | Insider transaction | 2026-08-03 | View → |
| 4 | Insider transaction | 2026-08-03 | View → |
| 4 | Insider transaction | 2026-08-03 | View → |
| 4 | Insider transaction | 2026-07-02 | View → |
| 4 | Insider transaction | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-07-01 | View → |
| 4 | Insider transaction | 2026-06-10 | View → |
| 4 | Insider transaction | 2026-06-10 | View → |
| 4 | Insider transaction | 2026-06-10 | View → |
| 4 | Insider transaction | 2026-06-10 | View → |
| 8-K | FORM 8-K | 2026-06-10 | View → |
| 4 | Insider transaction | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 8-K | 8-K | 2026-05-22 | View → |
| 8-K | 8-K | 2026-05-18 | View → |
| 10-Q | 10-Q | 2026-05-14 | View → |
| 4 | Insider transaction | 2026-05-12 | View → |
| 4 | Insider transaction | 2026-05-01 | View → |
| 4 | Insider transaction | 2026-05-01 | View → |
| 4 | Insider transaction | 2026-05-01 | View → |
| 4 | Insider transaction | 2026-05-01 | View → |
| 4 | Insider transaction | 2026-05-01 | View → |
| 4 | Insider transaction | 2026-05-01 | View → |
| 8-K | 8-K | 2026-04-28 | View → |
| DEF 14A | DEF 14A | 2026-04-28 | View → |
| 8-K | 8-K | 2026-04-22 | View → |
| 8-K | 8-K | 2026-04-07 | View → |
| 4 | Insider transaction | 2026-04-02 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $12.17
- Market Cap
- $410.64 million
- 52-Week Range
- $5.65 – $13.25
- Average Volume
- 183K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.